In several cancer forms, high expression of ezrin has been associated with more aggressive tumours [13-19], whereas in serous ovarian carcinoma, lost expression of ezrin correlated with a worse prognosis [20], similar to the findings in bladder cancer [7]. This evidence concerns the gene EZR and cancer.